AI Article Synopsis
- - The COVID-19 pandemic, caused by SARS-CoV-2, has significant implications for public health, environmental quality, and socio-economic systems globally.
- - Despite a drop in air pollutants like NO2 and PM2.5, cities with high pollution rates experienced increased mortality rates during the pandemic, highlighting environmental health interconnections.
- - The pandemic's socio-economic effects include increased health budgets, disruptions in industries, job losses, and a shift in waste management practices, indicating a broader economic strain on countries.
Article Abstract
The COVID-19 pandemic caused by SARS-CoV-2 has emerged as a global issue of concern for public health, environment and socio-economic setup. This review addresses several aspects of epidemiology, and pathogenesis, environmental resource quality (air quality, hazardous waste management, and wastewater surveillance issues), and socio-economic issues worldwide. The accelerated research activity in the development of diagnostic kits for SARS-CoV-2 is in progress for the rapid sequencing of various strains of SARS-CoV-2. A notable reduction in air pollutants (NO2 and PM2.5) has been observed worldwide, but high air polluted cities showed intense mortalities in COVID-19 affected areas. The use of health safety equipment halted transportation, and work-from-home policy drastically impacted the quantity of solid and hazardous wastes management services. Wastewater appeared as another mode of enteric transmission of SARS-CoV-2. Thus, wastewater-based surveillance could act as a mode of the data source to track the virus's community spread. The pandemic also had a substantial socio-economic impact (health budget, industrial manufacturing, job loss, and unemployment) and further aggravated the countries' economic burden.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687413 | PMC |
| http://dx.doi.org/10.1016/j.jenvman.2020.111700 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluating convalescent plasma therapy in severe COVID-19: a retrospective cohort study.
J Infect Dev Ctries
December 2024
Department of Pharmacology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Introduction: Convalescent plasma (CP) therapy is a form of passive immunization which has been used as a treatment for coronavirus disease 2019 (COVID-19). This study aims to evaluate the efficacy and safety of CP therapy in patients with severe COVID-19.
Methodology: In this retrospective cohort study, 50 patients with severe COVID-19 treated with CP at Shahid Beheshti Hospital, Kashan, in 2019 were evaluated.
Epidemiologic threats and outcome of evolving COVID-19-associated mucormycosis from a referral hospital in Egypt.
J Infect Dev Ctries
December 2024
Chest Dpt., Ahmed Maher Teaching Hospital, GOTHI, Cairo, Egypt.
Introduction: The present study aimed to explore the epidemiologic threats and factors associated with the coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) epidemic that emerged in Egypt during the second COVID-19 wave. The study also aimed to explore the diagnostic features and the role of surgical interventions of CAM on the outcome of the disease in a central referral hospital.
Methodology: The study included 64 CAM patients from a referral hospital for CAM and a similar number of matched controls from COVID-19 patients who did not develop CAM.
Demystifying the role of MMP9 and TIMP-1 as markers of lung imaging and functional abnormality of COVID-19.
J Infect Dev Ctries
December 2024
Department of Pulmonary and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Introduction: This study aimed to analyze the levels of MMP-9 and TIMP-1 as biomarkers for identifying lung anatomical and functional abnormalities in coronavirus disease 2019 (COVID-19).
Methodology: Adult COVID-19 patients hospitalized between October and December 2021 were included in the study. MMP-9 and TIMP-1 levels were measured from the blood.
The first reported case of candidemia caused by the novel Candida tropicalis diploid sequence type 1515.
J Infect Dev Ctries
December 2024
Department of Emergency Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Introduction: Since the dawn of the new millennium, Candida species have been increasingly implicated as a cause of both healthcare-associated as well as opportunistic yeast infections, due to the widespread use of indwelling medical devices, total parenteral nutrition, systemic corticosteroids, cytotoxic chemotherapy, and broad-spectrum antibiotics. Candida tropicalis is a pathogenic Candida species associated with considerable morbidity, mortality, and drug resistance issues on a global scale.
Methodology: We report a case of a 43-year-old man who was admitted to our hospital for further management of severe coronavirus disease 2019 (COVID-19) pneumonia.
Antimicrobial consumption and resistance in a tertiary care hospital in Brazil: a 7-year time series.
J Infect Dev Ctries
December 2024
Faculdade de Farmácia, Universidade Federal de Minas Gerais, Brazil.
Introduction: Antimicrobial resistance (AMR) is a major public health challenge globally. This study aimed to analyze the antibacterial consumption (ATBc), and the incidence of multidrug-resistant organisms (MDRO), focusing on pathogens Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE group), in a Brazilian tertiary care hospital.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!